Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXUN6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,644
Award facts
- Contract value 100% obligated
- $10,643.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 20, 2026, the Defense Logistics Agency awarded a delivery order valued at $10,643.70 to AmerisourceBergen Drug Corp for the supply of Wegovy 2.4 mg/0.75 mL pens. The contract is a firm fixed-price delivery order with an ultimate completion date of January 21, 2026, and represents a non-set-aside competitive award. Performance will occur at the awardee's location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains through competitive, firm fixed-price arrangements with the Defense Logistics Agency. The parent company Cencora, Inc. maintains significant contract vehicles with multiple federal agencies, including the Department of Justice Federal Bureau of Investigation, positioning the organization to efficiently deliver essential pharmaceutical and medical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FXUN6?
SPE2DR26FXUN6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FXUN6 worth?
The government has obligated $10,644 on SPE2DR26FXUN6.
Is contract SPE2DR26FXUN6 an order under another contract?
Yes. SPE2DR26FXUN6 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXUN6 competed?
The extent of competition for SPE2DR26FXUN6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award